help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.
Right arrow Articles by Wand, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.
Right arrow Articles by Wand, G. S.
Molecular Endocrinology 11 (8): 1053-1061
Copyright © 1997 by The Endocrine Society

Increased Expression Of Gs{alpha} Enhances Activation Of The Adenylyl Cyclase Signal Transduction Cascade

Xioaju Yang, Francis Y. G. Lee Sr. and Gary S. Wand

Departments of Medicine and Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Expression of the stimulatory G protein, Gs{alpha}, can vary over a 3-fold range in human tissues and in rodent central nervous system. In fact, the offspring of alcoholics have higher levels of Gs{alpha} expression in certain tissues compared with the offspring of nonalcoholics. The aim of this research was to test the hypothesis that a causal relationship exists between the level of expression of Gs{alpha} and induction of the adenylyl cyclase (AC) cascade. The methodology employed transient transfection of HEK 293 cells with a cDNA for the 52-kDa form of Gs{alpha} under regulation by inducible metallothionein promoters. Transfectants were exposed to varying concentrations (0–125 µM) of zinc sulfate that produced a 3-fold range of membrane Gs{alpha} expression. The range of Gs{alpha} expression produced was found to mimic a physiologically relevant spectrum of Gs{alpha} expression in membranes derived from human tissues and rat brain. It was observed that induction of Gs{alpha} expression increased constitutive as well as stimulated cAMP accumulation. Moreover, induction of Gs{alpha} expression increased events distal to the accumulation of cAMP including the phosphorylation of the transcription factor, cAMP response element binding protein and transcriptional activation of cAMP-dependent reporter genes. In summary, these studies show that the amount of Gs{alpha} expression has a marked impact on the level of activity of the AC cascade from the membrane through to the nucleus. It is hypothesized that individuals who differ in Gs{alpha} expression may also differ in the expression of certain cAMP-dependent genes.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
G. F. Lehnerdt, P. Franz, A. Zaqoul, K. J. Schmitz, S. Grehl, S. Lang, K. W. Schmid, W. Siffert, K. Jahnke, and U. H. Frey
Overall and Relapse-Free Survival in Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma Are Associated with Genotypes of T393C Polymorphism of the GNAS1 Gene
Clin. Cancer Res., March 15, 2008; 14(6): 1753 - 1758.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Romano, K. Magalon, M. Pertuit, R. Rasolonjanahary, A. Barlier, A. Enjalbert, and C. Gerard
Conditional Overexpression of the Wild-Type Gs{alpha} as the gsp Oncogene Initiates Chronic Extracellularly Regulated Kinase 1/2 Activation and Hormone Hypersecretion in Pituitary Cell Lines
Endocrinology, June 1, 2007; 148(6): 2973 - 2983.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
U. H. Frey, H. Nuckel, L. Sellmann, D. Siemer, R. Kuppers, J. Durig, U. Duhrsen, and W. Siffert
The GNAS1 T393C Polymorphism Is Associated with Disease Progression and Survival in Chronic Lymphocytic Leukemia.
Clin. Cancer Res., October 1, 2006; 12(19): 5686 - 5692.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
J. V. Selkirk, L. M. Nottebaum, I. C. Ford, M. Santos, S. Malany, A. C. Foster, and S. M. Lechner
A Novel Cell-Based Assay for G-Protein-Coupled Receptor-Mediated Cyclic Adenosine Monophosphate Response Element Binding Protein Phosphorylation
J Biomol Screen, June 1, 2006; 11(4): 351 - 358.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
U. H. Frey, G. Lummen, T. Jager, K.-H. Jockel, K. W. Schmid, H. Rubben, N. Muller, W. Siffert, and A. Eisenhardt
The GNAS1 T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma
Clin. Cancer Res., February 1, 2006; 12(3): 759 - 763.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Tyson-Capper, J. Bailey, A. R. Krainer, S. C. Robson, and G. N. Europe-Finner
The Switch in Alternative Splicing of Cyclic AMP-response Element Modulator Protein CREM{tau}2{alpha} (Activator) to CREM{alpha} (Repressor) in Human Myometrial Cells Is Mediated by SRp40
J. Biol. Chem., October 14, 2005; 280(41): 34521 - 34529.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
U. H. Frey, H. Alakus, J. Wohlschlaeger, K. J. Schmitz, G. Winde, H. G. van Calker, K.-H. Jockel, W. Siffert, and K. W. Schmid
GNAS1 T393C Polymorphism and Survival in Patients with Sporadic Colorectal Cancer
Clin. Cancer Res., July 15, 2005; 11(14): 5071 - 5077.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
U. H. Frey, A. Eisenhardt, G. Lummen, H. Rubben, K.-H. Jockel, K. W. Schmid, and W. Siffert
The T393C Polymorphism of the G{alpha}s Gene (GNAS1) Is a Novel Prognostic Marker in Bladder Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 871 - 877.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Bailey, A. J Tyson-Capper, K. Gilmore, S. C Robson, and G N. Europe-Finner
Identification of human myometrial target genes of the cAMP pathway: the role of cAMP-response element binding (CREB) and modulator (CREM{alpha} and CREM{tau}2{alpha}) proteins
J. Mol. Endocrinol., February 1, 2005; 34(1): 1 - 17.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Kull, P. Svenningsson, and B. B. Fredholm
Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum
Mol. Pharmacol., October 1, 2000; 58(4): 771 - 777.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
J. Bailey, C. Sparey, R. J. Phillips, K. Gilmore, S. C. Robson, W. Dunlop, and G.N. Europe-Finner
Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour
Mol. Hum. Reprod., July 1, 2000; 6(7): 648 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. C. Carel, C. Le Stunff, L. Condamine, E. Mallet, J. L. Chaussain, P. Adnot, M. Garabédian, and P. Bougnères
Resistance to the Lipolytic Action of Epinephrine: A New Feature of Protein Gs Deficiency
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4127 - 4131.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Barlier, I. Pellegrini-Bouiller, G. Gunz, A. J. Zamora, P. Jaquet, and A. Enjalbert
Impact of gsp Oncogene on the Expression of Genes Coding for Gs{alpha}, Pit-1, Gi2{alpha}, and Somatostatin Receptor 2 in Human Somatotroph Adenomas: Involvement in Octreotide Sensitivity
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2759 - 2765.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Ballaré, S. Mantovani, A. Lania, A. M. Di Blasio, L. Vallar, and A. Spada
Activating Mutations of the Gs{alpha} Gene Are Associated with Low Levels of Gs{alpha} Protein in Growth Hormone-Secreting Tumors
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4386 - 4390.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Barlier, G. Gunz, A. J. Zamora, I. Morange-Ramos, D. Figarella-Branger, H. Dufour, A. Enjalbert, and P. Jaquet
Pronostic and Therapeutic Consequences of Gs{alpha} Mutations in Somatotroph Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1604 - 1610.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society